Cargando…
Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
Autores principales: | Kasperkiewicz, Michael, Tukaj, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806130/ https://www.ncbi.nlm.nih.gov/pubmed/36600888 http://dx.doi.org/10.3389/fmed.2022.1096867 |
Ejemplares similares
-
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Pira, Anna, et al.
Publicado: (2023) -
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022) -
Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens
por: Kasperkiewicz, Michael, et al.
Publicado: (2021) -
May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022) -
Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19
por: Kasperkiewicz, Michael, et al.
Publicado: (2022)